Abstract
Impairment of cognitive function poses a major concern in elderly patients. A cholinergic deficit that accompanies the normal aging process is thought to contribute to cognitive decline. Most anticholinergic drugs block central muscarinic receptors, which mediate cognitive effects such as attention, learning, and short‐term memory. Even though the causes of cognitive impairment in elderly patients are multifactorial, anticholinergic drugs or drugs with anticholinergic properties contribute significantly to the development of cognitive impairment in these patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
